Chem. J. Chinese Universities ›› 2019, Vol. 40 ›› Issue (5): 909.doi: 10.7503/cjcu20180828

• Organic Chemistry • Previous Articles     Next Articles

Synthesis and Biological Activities of Myricetin Derivatives Containing Quinoxaline

LI Pu, CHEN Ying, XIA Rongjiao, GUO Tao, ZHANG Min, JIANG Shichun, ANG Xu, HE Ming, XUE Wei*()   

  1. State Key Laboratory Breeding Base of Green Pesticide and Agricultural Bioengineering, ey Laboratory of Green Pesticide and Bioengineering of Ministry of Education, enter for Research and Development of Fine Chemicals,Guizhou University, Guiyang 550025, China
  • Received:2018-12-10 Online:2019-04-12 Published:2019-04-12
  • Contact: XUE Wei E-mail:wxue@gzu.edu.cn
  • Supported by:
    † Supported by the National Key Research and Development Program of China(No. 2017YFD0200506), the National Natural Science Foundation of China(No. 21867003) and the Science and Technology Plan Project of Guizhou Province, China(No. 20185781)

Abstract:

According to the active substructure combination theory, a series of novel myricetin derivatives containing quinoxaline moieties was synthesized by introducing the quinoxaline blocks into the structures of myricetins. The antibacterial activities of the target compounds were evaluated via turbidimeter test in vitro. The preliminary bioassay results indicated that all of the title compounds exhibited certain antibacterial activities in vitro against Xanthomonas axonopodis pv. Citri(X. citri) and Xanthomonas oryzae pv. Oryzae(X. oryzae). The compounds were also tested to evaluate the half maximal effective concentration(EC50) of phytopathogenic bacteria. The results showed that all the X. citri EC50 of the target compounds were superior to those of the control drugs of bismerthiazol and thiodiazole copper(54.85 and 61.13 μg/mL, respectively). Compound 4o(EC50=11.17 μg/mL) exhibited the best activity. All of the X. oryzae EC50 of the target compounds were superior to the control drugs of bismerthiazol and thiodiazole copper(148.20 and 175.47 μg/mL, respectively). Compound 4f(EC50=34.49 μg/mL) exhibited the best activity. The in vivo efficacies against tobacco mosaic virus(TMV) of the target compounds were tested through half-leaf method. The results of bioassay showed that the target compounds exhibited certain anti-TMV activities at the concentration of 500 mg/L.

Key words: Myricetin, Quinoxaline, Antibacterial activity, Anti-TMV activity

CLC Number: 

TrendMD: